Clinical Effectiveness of MyNutriKidney®
Launched by UNIVERSITI PUTRA MALAYSIA · May 1, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of a mobile health app called MyNutriKidney®, designed to help people with Chronic Kidney Disease (CKD) manage their diets better. The trial will last for 6 months and involve 200 adults with CKD stages 3 to 5. Participants will be randomly assigned to either use the MyNutriKidney® app along with standard care (which includes dietary counseling) or to receive only standard care. The main goals are to see how well participants follow a kidney-friendly diet and understand nutritional information by the end of the study.
To be eligible for this trial, participants must be at least 18 years old, have a diagnosis of CKD, and own a smartphone that can run the app. They should also be able to understand and communicate in English, Bahasa Melayu, or Mandarin. Participants will need to be able to give informed consent and be mentally capable of participating in the study. Unfortunately, those with significant cognitive issues, severe visual or motor problems, or who are currently receiving specific treatments like cancer therapy can't take part. If you or someone you know is interested and meets these criteria, this trial could be a great opportunity to improve dietary management for CKD.
Gender
ALL
Eligibility criteria
- • Participants must meet all of the following inclusion criteria and none of the exclusion criteria to be eligible for enrolment into the study.
- Inclusion Criteria:
- 1. Clinically diagnosed Chronic Kidney Disease (CKD):
- • 1.1. eGFR \< 60 ml/min/1.73m² for ≥ 3 months (applicable to pre-dialysis patients, Stages 3-5)
- • 2. Aged 18 years or older.
- • 3. Possesses a personal smartphone compatible with the MyNutriKidney® application and is willing to use the health app if randomized to the intervention group.
- • 4. Alert and oriented, and deemed capable of providing informed consent and participating in study procedures.
- • 5. Able to communicate and understand study procedures in English, Bahasa Melayu, or Mandarin.
- Exclusion Criteria:
- • 1. Inability to effectively use the smartphone application due to significant impairments (e.g., severe visual or motor problems).
- • 2. Smartphone owned by the participant does not meet the minimum technical requirements for the MyNutriKidney® application installation and operation
- • 3. Presence of significant cognitive impairment or severe psychological conditions (e.g., uncontrolled anxiety or depression) likely to impede consistent participation or adherence to study requirements.
- • 4. Known unwillingness or inability to comply with core study procedures, including dietary assessment components.
- • 5. Concurrent participation in another interventional research study.
- • 6. Participation in another research study involving an investigational product in the 12 weeks preceding potential enrollment.
- • 7. Female participants who are pregnant, currently lactating, or planning a pregnancy during the course of the trial.
- • 8. Currently receiving primary nutritional support via enteral tube feeding or parenteral (intra-venous) nutrition.
- • 9. Currently receiving active treatment for cancer (e.g., chemotherapy, radiotherapy).
About Universiti Putra Malaysia
Universiti Putra Malaysia (UPM) is a prestigious research university located in Malaysia, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, UPM leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the global body of medical knowledge. The university fosters collaboration among multidisciplinary teams, ensuring that its clinical trials adhere to the highest ethical and regulatory standards while addressing critical health challenges. Through its initiatives, UPM plays a vital role in translating scientific findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kajang, Selangor, Malaysia
Patients applied
Trial Officials
Nor Fadhlina binti Zakaria, Nephrologist
Principal Investigator
Universiti Putra Malaysia
Barakatun Nisak binti Mohd Yusof, Dietitian Professor [Dr]
Principal Investigator
Universiti Putra Malaysia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported